BioNTech SE (BNTX)

NASDAQ: BNTX · Real-Time Price · USD

101.61

-0.47 (-0.46%)

At close: Aug 31, 2026, 4:00 PM EDT

101.55

-0.06 (-0.06%)

Pre-market: Sep 1, 2026, 4:14 AM EDT

BioNTech SE Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	25,525	22,891	27,318	25,088	36,506	62,264
Market Cap Growth	3.07%	-16.20%	8.89%	-31.28%	-41.37%	217.21%
Enterprise Value	10,504	6,321	8,960	8,633	23,607	59,821
Last Close Price	101.61	95.20	113.95	105.54	150.22	255.33

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	24.40	3.62	5.32
Forward PE	-	100.62	100.62	67.81	8.27	8.07
PS Ratio	8.43	6.79	9.59	5.94	1.97	2.89
PB Ratio	1.26	1.01	1.36	1.12	1.70	4.60
P/TBV Ratio	1.40	1.13	1.45	1.19	1.72	4.68
P/FCF Ratio	46.82	69.41	-	4.43	2.58	71.83
P/OCF Ratio	32.32	42.76	127.04	4.23	2.52	61.54
PEG Ratio	-	0.01	0.01	0.01	0.01	0.02

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	3.47	1.88	3.15	2.05	1.28	2.77
EV/EBITDA Ratio	-	-	-	7.04	1.84	3.53
EV/EBIT Ratio	-	-	-	8.04	1.85	3.54
EV/FCF Ratio	19.27	19.17	-	1.53	1.67	69.01

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.02	0.01	0.01	0.01	0.01	0.03
Debt / EBITDA Ratio	-	-	-	0.19	0.02	0.02
Debt / FCF Ratio	0.67	0.95	-	0.04	0.02	0.40
Net Debt / Equity Ratio	-0.74	-0.70	-0.80	-0.81	-0.69	-0.15
Net Debt / EBITDA Ratio	9.52	11.99	13.27	-14.71	-1.16	-0.12
Net Debt / FCF Ratio	-28.02	-47.96	197.84	-3.19	-1.05	-2.33
Asset Turnover	0.13	0.13	0.12	0.17	0.89	2.09
Inventory Turnover	3.74	3.10	1.69	1.51	6.36	10.28
Quick Ratio	7.03	6.87	6.88	9.12	7.19	4.15
Current Ratio	7.85	7.54	7.45	9.43	7.43	4.33
Return on Equity (ROE)	-9.30%	-5.88%	-3.36%	4.62%	59.06%	155.18%
Return on Assets (ROA)	-5.41%	-3.56%	-3.53%	2.62%	38.09%	102.25%
Return on Invested Capital (ROIC)	-36.69%	-26.47%	-33.23%	15.06%	106.34%	195.58%
Return on Capital Employed (ROCE)	-9.90%	-6.40%	-6.40%	4.60%	58.60%	120.20%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-7.55%	-5.83%	-2.52%	4.10%	27.62%	18.80%
FCF Yield	2.14%	1.44%	-0.30%	22.56%	38.78%	1.39%
Buyback Yield / Dilution	-3.00%	-0.54%	0.95%	2.84%	3.81%	-4.51%

SEC Filings: 10-K · 10-Q